StockGuru Blog: Immune Response was Pioneered by a Medical Legend: Dr. Jonas Salk, Developer of the First Polio Vaccine
IMNR - The Immune Response CorporationThe Immune Response Corp. Uses the Immune System to Treat Targeted Diseases: Multiple Sclerosis (MS) and HIV/AIDS The Immune Response Corporation was founded in 1986 by Dr. Jonas Salk, the developer of the first polio vaccine. Therapies in development at IMNR are based on using the body’s immune system to slow or stop the progression of the diseases. Two products in Phase II clinical trials are NeuroVax, targeting MS, and IR103 that targets HIV/AIDS. These therapies could be used alone or in combination with other drugs, enabling the Company to realize multi-billion dollar sales. Other…